Indefinite Delivery Contract W9114F22D0002

This federal contract IDV award to Bioscientia Institut FUR Medizinische Diagnostik GMBH, a for-profit organization, provides clinical reference laboratory testing services to the U.S. Defense Health Agency (DHA) and Department of the Army Medical Command. The Indefinite Delivery Contract (IDC), valued at up to $690,476.25, was awarded on May 1, 2022 and has an ultimate completion date of April 30, 2025. The contract serves as a vehicle for issuing delivery orders for these laboratory testing services, with no set-asides used. To date, at least two delivery orders have been issued against this IDC - one by DHA for $90,608.68 and another by the Army Medical Command for $114,652.42. These orders have performance periods through April 2023 and April 2024, respectively, and will be carried out at Bioscientia's facilities in Germany. The IDC supports the healthcare missions of these defense agencies by providing flexible access to Bioscientia's laboratory testing capabilities, including COVID-19 testing services previously provided to the Army. This contracting vehicle allows the agencies to efficiently procure critical patient care-related laboratory services over a multi-year period.

The original federal contract opportunity was a pre-solicitation announcement by the Regional Health Contracting Office-Europe for an Indefinite Delivery, Indefinite Quantity (ID/IQ) contract to provide non-personal clinical reference laboratory testing services to the Landstuhl Regional Medical Center (LRMC) in Germany. The solicitation was for full and open competition, with a Lowest Price Technically Acceptable (LPTA) evaluation approach. The contract aims to support the Department of Pathology and Area Laboratory Services (DPALS) at LRMC through the provision of these laboratory testing services in accordance with College of American Pathologists (CAP) standards.